InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Explore the complete record of transactions filed by Kirby John J., Chief Financial Officer. Insider active across 1 companies, notably Idera Pharmaceuticals, INC.. Cumulatively, 2 reports have been published. Total volume traded: €11k. The latest transaction was disclosed on 17 December 2021 — Acquisition. Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations2 total
€5,42610,000 shares@ €0.5426100.0% of flow
Common Stock
SEC:0001415889-21-006155·
Ideal exit: 13 Sept 2022 (T+270)
€5,42610,000 shares@ €0.542650.0% of flow
Common Stock
SEC:0001415889-21-006155:0·
Ideal exit: 13 Sept 2022 (T+270)
2 of 2 declarations
About Kirby John J.
Kirby John J. is the Chief Financial Officer of IDERA PHARMACEUTICALS, INC. He is responsible for managing the company's finances, including financial planning, risk management, and investment strategy. His role is crucial in ensuring the financial health of the organization and supporting its growth. Kirby John J. works closely with other executives to align financial objectives with the overall strategy of the company.
